KANKAKEE, IL (November 15, 2023) – The Riverside Cancer Institute in Kankakee, Illinois, has been named a “Great Oncology Program” by Becker’s Hospital Review. This recognition is part of an annual list released by Becker’s, spotlighting hospitals and health systems with leading oncology programs.
Phil Kambic, Riverside’s President and CEO, expressed pride in the institute’s commitment to providing advanced cancer treatment technology locally. Recently, Riverside enhanced its capabilities by adding a second TrueBeam linear accelerator, known for its precision in targeting cancerous tumors while minimizing damage to healthy tissue.
The Riverside Cancer Institute offers a comprehensive range of services, including a team of oncologists, nurse practitioners, and support staff dedicated to patient care. Kirstin Carson, Director of Oncology and Infusion Services, highlighted the team’s dedication to patient care as a key factor in earning this distinction.
For the complete list of “100 Hospitals and Health Systems with Great Oncology Programs” by Becker’s Hospital Review, readers are directed to their website.
